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The following document is the transcript for the Mantoux 
Tuberculin Skin Test DVD. Incorporated within the transcript 
are facilitator notes offering suggestions for discussion during 
a training conducted with this DVD.   
 
Facilitator notes are identified by a note symbol 
followed by a text box. 
 
To begin, insert the DVD into the CD drive on your 
computer. If the DVD does not start automatically, double-
click on the My Computer Icon on your desktop and double-
click on the CD drive to access the menu. You can play all 
sections or choose the section that you would like to view.  










An estimated 2 billion people, or one third of the 
world's population, are infected with the bacteria 
that cause tuberculosis. One reason so many 
people are infected with TB is that it’s spread 
through the air from one person to another. 
When someone with TB disease of the lungs or 
throat coughs or sneezes, the bacteria are expelled 
into the air. If people nearby breathe in these 
bacteria, they can become infected, and usually 
the infection remains latent. 
In latent TB infection, the bacteria are made 
inactive by the body’s immune system. The 
bacteria can remain inactive for many years, 
perhaps for life. Most people who become infected 
with TB don’t get active TB disease. 
However, an infected person remains at risk of 
developing active TB disease at any time. The 
bacteria can become active and multiply, 
especially if the immune system becomes 
impaired.  
The bad news is, approximately 2 million people 
in the world die each year from active TB disease. 
The good news is, people who have latent TB 
infection can get treatment that will prevent the 
development of active TB disease. 
As a health care worker, you play an important 
role in controlling TB. Your knowledge and skills 
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are valuable in accurately identifying people who 




In this video you’ll learn how to test for TB 
infection by administering and reading the 
Mantoux tuberculin skin test. 
The Mantoux tuberculin skin test should always 




Discuss skin test training, certification 
programs, and requirements in your 
locality. In your work site: 
 What type of health care worker is 
designated to place and read the 
skin test: a nurse, outreach worker, 
or someone else?  
 Is placing and reading done by one 
person or different people? 
 What courses must be taken by 
health care workers who place and 
read the skin test?  
 Are there required renewal classes? 
 Where and how often is this 
renewal training offered? 
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In the United States, the Mantoux tuberculin skin 
test has been the standard method for detecting 
latent TB infection since the 1930s. 
The skin test is used to evaluate people for latent 
TB infection. It’s primarily used in two situations.  
First, it’s used in contact investigations to test 
close contacts of people who have active TB 
disease. 
Second, it’s used as part of targeted testing 
activities in various groups of people who are at 
high risk for TB, such as health care workers who 
serve high-risk clients, residents and employees of 
correctional facilities, and foreign-born people 
from areas that have a high TB incidence.  
The priorities for targeted testing of high-risk 
populations should be based on local 
epidemiologic data.  
Once you’ve decided who should be tested, then 
you can begin the Mantoux tuberculin skin test 
procedure.  
The two main parts are administering and reading 
the skin test. 
 Discuss the targeted testing program at 
your facility. 
 What are the priorities for testing at 
your facility? 
 Which populations or target groups 
should be considered for testing? 
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This part of the procedure includes preparation 
steps, injection steps, and final steps. 
The preparation steps include collecting supplies, 
providing patient education, washing your hands, 
locating and cleaning the injection site, and 
preparing the syringe.  
When preparing to administer the Mantoux 
tuberculin skin test, make sure that the area for 
administering the test has a firm, well-lit surface, 
and that equipment and supplies are ready.  
Supplies should include a vial of tuberculin, a 
single-dose disposable tuberculin syringe, a ruler 
with millimeter (mm) measurements, 2x2 gauze 
pads or cottonballs, alcohol swabs, a puncture-
resistant sharps disposal container, record-keeping 





 are the two commercially 
available tuberculin products. The multidose vials 
contain tuberculin for either 10 or 50 tests.  
The tuberculin is administered using a single-dose 
disposable tuberculin syringe that has a one-
quarter to one-half inch, 27-gauge needle with a 
short bevel.   
In the United States, the Mantoux tuberculin skin 
test consists of an intradermal injection of exactly 
one tenth of a milliliter (mL), which contains 5 
tuberculin units.  
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Syringe and needle technologies continue to 
evolve to help prevent needlestick injuries. 
Institutional policy should determine which skin 
test device has been evaluated and approved for 







Look at the vial label to make sure the vial 
contains the tuberculin that you want to use, 
including the tuberculin unit strength.  
The label should indicate the expiration date. If 
it’s been open more than 30 days or the expiration 
date has passed, the vial should be thrown away 
and a new vial used.  
When you open a new vial, write the date and 
your initials on the label to indicate when the vial 
was opened and who opened it.  
To avoid reducing the potency of the tuberculin, 
store it inside a refrigerator so that it remains 
between 35 and 46 degrees Fahrenheit or between 
2 and 8 degrees Centigrade.  
Also store and transport the tuberculin in the dark 
as much as possible and avoid exposure to light.  
In certain settings, such as when you’re in the 
field, you may need to use another type of cooling 
container to control the temperature and protect 
from light.  
Discuss and demonstrate the needle 
technology that has been selected for 
use at your facility.  












After collecting supplies, the next step is patient 
education. You should sit so that you are both 
comfortable and facing each other.  
Discuss why the skin test is given, what is 
involved in the procedure, and when the patient 
should return for the test to be read. Explain that 
48 to 72 hours after the test is administered, the 
patient must return to have the induration 
measured and evaluated. Make an appointment for 
the patient to return.  
If a patient can’t return within the 48- to 72-hour 
time period, do not administer the test. Instead, 
schedule another time that allows the patient to 
come for both the test and the return appointment. 
It’s also important to encourage the patient to ask 
questions and talk about any anxieties he or she 
may have about the test.  
That way you can answer any questions and ease 
any fears the patient may have. Consult local 
practice to find out how best to document 
informed consent in your setting.  
Discuss the type of cooling device used 
by your facility in settings when a 
refrigerator is not nearby.  
Discuss whether or not your program 
has a consent form that must be signed 
by the patient or another way to ensure 
informed consent. Also discuss 
translation options for patients who do 
not speak English. 
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After providing patient education, you should 
wash your hands, using an appropriate hand-
washing technique, before administering the test 
or any other procedure involving patient contact. 
In certain field settings it may be necessary to use 









On a firm, well-lit surface, expose the patient’s 
arm and slightly flex it at the elbow. The injection 
should be placed on the palm-side-up surface of 
the forearm, about 2 to 4 inches below the elbow. 
Your local institutional policy may specify the 
right or the left forearm for the skin test.  
The area selected should be free of any barriers to 
placing and reading the skin test such as muscle 
margins, heavy hair, veins, sores, or scars.  
If the patient has any of these at the site, then you 
should use the other arm or the standard 
alternative site selected by your institution.  
Review the steps for appropriate hand 
washing and hand hygiene. Discuss the 
alternatives available in settings where 
soap and water are not accessible. For 
more information see “Guideline for 
Hand Hygiene in Healthcare Settings,” 
MMWR, Vol. 51, No. RR-16, October 
25, 2002. This guideline is also 
available on-line at 
http://www.cdc.gov/handhygiene/. 





























After choosing the injection site, clean the area 
with an alcohol swab by circling from the center 
of the site outward. Allow the site to dry 
completely before the injection. Because some of 
the tuberculin solution can adhere to the inside of 
the plastic syringe, the skin test should be given as 
soon as possible after the syringe is filled.  
Always follow your institution’s standard 
precautions for infection control.  
 
The DVD demonstrates consistent 
placement on the left arm. Typically, the 
other arm is used as the alternate site; 
however, in some situations other 
alternatives need to be considered (the 
shoulder is demonstrated as an alternative 
site, as it is often selected in patients who 
have less skin turgor). Describe the skin 
test placement site selection standards for 
your facility. 
 What is the standard arm used for 
placement? 
 What is the standard alternative site if 
there are barriers to placing on that 
arm? 
 Are there any other alternative sites? 
Discuss the importance of documenting the 
alternative site in the patient’s chart or 
other record-keeping forms. 
Discuss your institution’s policies for 
infection control while placing the skin 
test. Scenes in the DVD demonstrate 
placement with gloves and without gloves. 
Discuss whether gloves are used in your 
facility, and under what circumstances. 











Wipe the top of the vial with a new alcohol swab 
before drawing up the tuberculin solution.  
Pick up the syringe and be sure to fasten the 
needle tightly on the syringe by holding the cap 
and twisting it onto the tip of the syringe. Next, 
remove the needle cap.  
The needle bevel should be perpendicular to the 
flange of the syringe. If necessary, turn and tighten 
the needle to line up the bevel correctly with the 
flange.  
Place the vial on a flat surface, hold the vial 
between the thumb and fingers, and insert the 
needle through the neoprene stopper.  
Invert the vial while keeping a firm hold on the 
syringe and plunger. The tip of the needle should 
be below the fluid level in the vial.  
Pull back on the plunger and draw out slightly 
more than the one tenth of a milliliter needed for 
the test.  
Remove the needle from the vial. Hold the syringe 
in an upright position, then draw back slightly on 
the plunger. Tap the syringe lightly to break up air 
bubbles, then push forward.  
Expel all air and excess fluid from the syringe and 
needle, leaving exactly one tenth of a milliliter of 
tuberculin solution in the syringe. 
The second step in administering the Mantoux 
tuberculin skin test is injection. You’ll inject the 
  11 
tuberculin, discard the needle and syringe, check 
that the skin test was administered properly, and 

















Stretch taut the selected area of skin between the 
thumb and forefinger.  
This provides a surface that is easier for the needle 
to penetrate. With the needle bevel facing up and 
the syringe flange parallel to the forearm, hold the 
syringe between your thumb and forefinger.  
The Mantoux tuberculin skin test is an intradermal 
injection.  
With the needle bevel against the patient’s skin, 
insert it slowly at a 5- to 15-degree angle.  
The 5- to 15-degree angle is very important 
because this layer of skin is very thin.  
For an intradermal injection, the needle bevel is 
advanced through the epidermis, the superficial 
layer of skin, approximately 3 mm so that the 
entire bevel is covered and lies just under the skin.  
The injection will produce inadequate results if the 
needle angle is too deep or too shallow.  
There are several techniques for pulling the 
skin taut for placement (e.g., pulling from 
under the arm, inserting with one hand from 
the side, pulling toward the wrist with one 
finger). Only two techniques are 
demonstrated in the DVD. If a different 
technique is used at your facility, describe it. 
  12 
When the needle is inserted at the correct angle 
you can see the bevel of the needle just below the 
skin surface.  Next, release the stretched skin and 








Grip the flange of the syringe between your first 
and middle fingers. Use your thumb to press on 
the plunger.  
Now, slowly inject the tuberculin solution. You 
should feel fairly firm resistance as the tuberculin 
enters the skin.  A tense, pale wheal that’s 6 to 10 
mm in diameter appears over the needle bevel. 
Remove the needle without pressing or massaging 
the area.  
Next, discard the used syringe immediately in the 
designated puncture-resistant container.  
If you’re using a safety needle, engage the safety-
needle mechanism before discarding.  
To prevent needlestick injuries, used needles 
should not be recapped, purposely bent or broken, 
removed from disposable syringes, or otherwise 
manipulated by hand.  
It’s not unusual for a drop of blood to appear at 
the injection site, even when the needle is inserted 
properly.   
Should this happen, lightly blot the blood away 
with a 2x2 gauze pad or cotton ball.  Do not cover 
the site with an adhesive bandage because the 
adhesive could cause irritation and interfere with 
the test. Properly dispose of the contaminated 
gauze pad. To determine if the skin test was 
administered properly, use the millimeter ruler to 
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The wheal should be at least 6 mm in diameter.  
If the wheal is less than 6 mm in diameter, then 
the test should be administered again.  
The needle bevel may have been inserted too 
deeply or an inadequate dose administered.  
If leakage occurs at the insertion site, the needle 
bevel may not have been inserted far enough for 
the bevel to be covered by the skin.  
If the tuberculin test must be repeated, use another 
site at least 2 inches, or 50 mm, from the original 
site. Or use the standard alternate placement site. 
You will need to indicate this alternate site when 
you fill out the record keeping forms. 
The final step in administering the Mantoux 
tuberculin skin test includes washing your hands, 
recording information, reminding the patient about 
the return visit, providing patient education, and 
returning the vial to the refrigerator.  
In this step, immediately and thoroughly wash 
your hands.  
This step also includes recording information on 
the patient’s chart and other record-keeping forms. 
Write the date and the time the test was 
administered, the name and manufacturer of the 
injected solution, the lot number, the tuberculin 
dose administered, the expiration date, the forearm 
or alternative site in which the injection was 
given, the site location if you repeat the test, the 
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name of the person who administered the test, and 






Since it’s important for the patient to return within 
48 to 72 hours to have the test result read, always 
remind the patient to return. Giving the patient a 
card with information on care of the site and the 
date for the return appointment may help serve as 




Explain that mild itching, swelling, or irritation 
may occur and that these are normal reactions that 
do not require any treatment. These types of 
reactions usually go away within a week. Explain 
how to care for the injection site after the test.  
Tell the patient to avoid scratching the site, keep 
the site clean and dry, and avoid putting creams, 
lotions, or adhesive bandages on it. Also mention 
that getting the site wet with water is not harmful, 
but the site should not be wiped or scrubbed.  
Finally, return the tuberculin vial to the 
refrigerator or other cooling container if you are in 
the field. 
 
Provide copies of the record-keeping forms 
used at your facility and demonstrate how 
the information should be recorded. 
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Review of Part One 
 
In review, remember that when you administer the 
Mantoux tuberculin skin test, the preparation steps 
include collecting the supplies, providing patient 
education, washing your hands, locating and 





The injection steps include injecting the tuberculin 
at a 5- to 15-degree angle, discarding the needle 
and syringe properly, checking that the skin test 
was administered properly, and repeating the test 
if needed.  
The final steps include washing your hands, 
recording the information, reminding the patient 
about the return visit, providing patient education, 














Part Two: Reading the Mantoux Tuberculin Skin Test 
The last part of the procedure is to read the 
Mantoux tuberculin skin test. The method 
demonstrated in this videotape is based on the 
palpation method. The steps include 
collecting supplies; inspecting the site; palpating, 
marking, and measuring the induration; and 
recording the measurement.  
There are several different methods for reading the 
Mantoux tuberculin skin test, and they can vary 
among facilities.  For each facility, everyone 
reading the skin test should receive training in and 
use the same method.   
A great deal of practice is required to achieve 
consistently reliable measurements.  
The skin test should be read between 48 and 72 
hours after the skin test has been administered.  
A patient who doesn’t return within 72 hours will 
probably need to be rescheduled for another skin 
test.  
To begin, collect the following supplies: a small, 
plastic, flexible ruler marked in millimeters to 
measure the test, a pen to mark the edges of the 
induration, and an alcohol pad to clean off the pen 
marks. You’ll need the patient’s record or other 
appropriate forms for documenting the 
measurement results.  
A sharp eyeliner pencil and baby 
oil can be substituted for the pen 
and alcohol pad, to remove the 
marks easily. This is especially 
useful if blinded duplicate readings 
are done as part of quality control. 





















Also have culturally appropriate patient education 
materials available for the patient to reinforce 
information that is explained to the patient, help 
answer questions, and provide information on 
follow-up evaluation.  
To locate the skin-test site, inspect the arm in good 
light and on a firm surface. When the site is on the 
forearm, turn the arm palm up, support it, and 
slightly flex it at the elbow. 
The basis of reading the skin test is the presence or 
absence of induration, which is a hard, dense, 
raised formation. This is the area that is measured.  
Sometimes the site has erythema, a reddening of 
the skin that can also have swelling. The erythema 
should NOT be measured.  
Whatever induration is present at 48 to 72 hours 
should be measured and recorded. Only the part of 
the reaction that can be felt, which is the 
Patient education materials are 
available from CDC and the TB 
Regional Training and Medical 
Consultation Centers (See Appendix 
C). In addition, the TB Education and 
Training Resources website 
(http://www.findtbresources.org/scrip
ts/index.cfm) provides access to TB 
educational materials and other 
resources. Discuss the utility of 
sharing appropriate patient education 
materials with the patient prior to 
placing the test as well as prior to 
reading the test.  
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induration, is measured, even if there is soft 
swelling or redness at the site. Keep in mind there 














Reactions to the tuberculin test at the injection site 
can range from no induration to a large, well-
defined induration.  
In order to feel the induration properly, keep your 
fingernails short enough so that they don’t 
protrude beyond the finger.  
The induration is not always visible, so you must 
rely on palpation with your fingertips to discover 
if there’s induration at the site.  
With your fingers together, touch the area lightly 
with the pads of your fingertips.  
Using a light, gentle motion, sweep the fingertips 
over the surface of the forearm in a 2-inch 
diameter in all four directions to locate the 
margins or edges of induration.  
 
If induration is present, use a zigzag, feather-like 
touch over the area of induration to outline the 
margins of induration. Determining margins all 
around the induration helps to find the edges, 
which will be measured later.  
Explain how the fingertips are swept 
from north to south, south to north, east 
to west, and west to east. Explain that 
there should be no pushing or prodding 
to find the induration, only gentle 
sweeping motions. 
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When palpating for margins, be careful not to 
confuse a margin of induration with a margin of 
muscle on the forearm. To check this, raise the 
patient’s arm to a 45-degree angle and palpate 
again. You should still be able to palpate the 











The diameter of the induration is measured across 
the forearm, from the thumb side of the arm to the 
little finger side of the arm or vice versa. 
To mark the edges of the induration, hold your 
palm over the injection site with your fingertips at 
the outer edge of the patient’s forearm. Without 
lifting, move the fingertips from the outer edge of 
the forearm towards the induration. Rest one 
fingertip firmly against the induration margin 
border on one side before marking the margin. 
The fingertip should remain in contact with the 
skin at all times. Mark lightly with a fine dot at the 
widest edge of the induration, using the fingertip 
as a guide.   
Repeat the procedure from the other side of the 
patient’s forearm and place the second mark on 
the margin of induration. Palpate again to double 
check that the induration was marked correctly.  
If the margin is not equally clear all the way 
around the induration, it’s still necessary to mark 
the margins on each side of the induration. Palpate 
Explain that the orientation of the line 
of measurement can be remembered by 
visualizing the direction in which a 
watch-band lies across the arm. 
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around the induration from the easily felt margin 










If the margins of induration are irregular, mark 
and measure the longest diameter across the 
forearm.  
To measure the diameter of the induration, use the 
millimeter ruler.  
Place the zero ruler line inside the left dot edge 
and read the ruler line inside the right dot edge. If 
the measurement falls between two divisions on 
the millimeter scale, record the lower mark. The 
induration shown here measures 10 mm.  
Reactions to the skin test will vary. For example, 
this is a very large reaction with blistering, 
swelling, and redness.  
Make sure to record blistering, even if no 
induration is present. Palpate this induration 
gently, as it may be painful. Measure only the 
induration. 
This reaction measures 17 mm.  
There is redness and swelling in this reaction, but 
there is no induration. Because only the margins 
of induration are significant, the redness and 
swelling should not be mistakenly measured.  
Therefore, the measurement of this induration is 0 
mm.  
Immediately after the test is measured, write the 
exact measurement in millimeters of induration on 
the patient’s record. Do not simply record the 
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interpretation of the results as “negative” or 



















For example, an induration that measures 3 mm 
should be recorded as “3 mm” and not as 
“negative.”  Additional information should include 
the date and time the test was read, the name and 
signature of the person who read the skin test, and 
the presence or absence of adverse effects.  
State or local policies may require additional 
documentation of adverse effects.  
Accurately reading and recording skin test 
measurement results is important and gives the 
health care provider useful information for 
evaluation. Results are often used as a baseline or 
as a comparison with past or future test results.   
Interpretation should be performed by a trained 
health care provider in accordance with 
institutional policies based on CDC guidelines.  
Check your institution’s policy for evaluation and 
referral procedures.  
Discuss the documentation policies and 
procedures in your facility. Share a copy of the 
documentation form(s) that is used in your 
facility. Describe any additional 
documentation that may be necessary for 
reporting adverse effects (e.g., MedWatch 
forms). 

















Reliable reading of the tuberculin skin test 
requires a great deal of practice and adherence to 
appropriate steps for quality control.  
The steps in this method include standardization 
of procedures, training, supervision, and practice. 
This may include periodic standardized reliability 
testing.  
Discuss your facility’s policy for interpretation 
of the skin test measurement. If interpretation 
is conducted by the same person who reads the 
skin test, discuss cut points for interpretation 
(see Appendix D). If interpretation is 
conducted by someone else at your facility, 
discuss evaluation and referral procedures. 
Discuss the opportunities available for 
additional practice and training on the 
Mantoux tuberculin skin test in your facility. 
Discuss any reliability testing and supervision 
procedures that are used at your facility. 
 Who will supervise the readings? 
 How many readings need to be 
performed before supervision is no 
longer necessary? 
  23 




In review, remember: when you read the Mantoux 
tuberculin skin test, you should collect the 
appropriate supplies; inspect the site; palpate the 
induration; mark the induration; measure the 
induration, not the erythema; and record the 
measurement.  





Although it takes practice to perform the Mantoux 
skin test accurately and reliably, the skills and 
knowledge you develop in administering and 
reading the Mantoux tuberculin skin test will help 
you play an important role in TB control. 
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Appendix A: Mantoux Tuberculin Skin Test 
References 
 
Diagnostic Standards / Classification of TB in 
Adults and Children - Am J Respir Crit Care Med 
2000; 161:1376-1395 
http://www.cdc.gov/tb/publications/PDF/1376.pdf  
Targeted Tuberculin Testing and Treatment of 
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Appendix B: Ordering Information 
 
The Mantoux Tuberculin Skin Test Training Materials Kit 
may be ordered: 
 Through the Division of Tuberculosis 
Elimination (DTBE) online ordering system: 
http://www.cdc.gov/tb/ 
 
 By mailing the DTBE Educational and 
Training Materials Order Form, available at  
http://www.cdc.gov/tb/ 
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Additional resources and information on the Mantoux 
tuberculin skin test can be obtained from the Division of 
Tuberculosis Elimination, CDC and the TB Regional 
Training and Medical Consultation Centers. 
Centers for Disease Control and Prevention 
National Center for HIV/AIDS, Viral Hepatitis, STD, 
and TB Prevention 
Division of Tuberculosis Elimination 
1600 Clifton Road, MS E-10 
Atlanta, GA 30333 
http://www.cdc.gov/tb/ 
TB Regional Training and Medical Consultation Centers 
Curry International Tuberculosis Center  
300 Frank H. Ogawa Plaza, Suite 520  




New Jersey Medical School Global Tuberculosis 
Institute 
University of Medicine and Dentistry of New Jersey 
225 Warren Street, Second Floor East Wing 
Newark, NJ 07103-3620 
Phone: (973) 972-3270  
Fax: (973) 972-3268 
Information Line: 1-800-4TB-DOCS (482-3627) 
http://www.umdnj.edu/globaltb/start.html 
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Heartland National Tuberculosis Center  
2303 SE Military Drive 
San Antonio, TX 78223-3542 






Southeastern National Tuberculosis Center  
2055 Mowry Road 
Gainesville, FL 32611 
Mailing Address:  
PO Box 103600 







Mayo Clinic Center for Tuberculosis 
Centerplace Building 05  
200 First St. SW  
Rochester, MN 55905 
Phone: 855-360-1466 (toll-free) 
email: tbcenter@mayo.edu  
Website: http://www.mayo.edu/tuberculosis-center
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Appendix D: 




Skin test interpretation depends on  
(1) the measurement in millimeters (mm) of the 
induration and  
(2) the person’s risk of being infected with TB and/or 
progression to disease if infected.  
The following three cut points should be used to 
determine whether the skin test reaction is positive.  A 
measurement of 0 mm or anything below the defined cut 
point for each category is considered negative. 
Induration of 5 
mm is considered 
positive in 
Induration of 10 
mm is considered 
positive in 
Induration of 







 Recent contacts 
of TB case 
patients 












equivalent of 15 
mg/d of 
 Recent immigrants 
(i.e., within the 
last 5 years) from 
high-prevalence 
countries 
 Injection drug 
users 
 Residents and 
employees
†




and jails, nursing 
homes and other 
long-term 
facilities for the 
elderly, hospitals 
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prednisone for 1 
month or more. 















 Persons with the 
following clinical 
conditions that 











carcinoma of the 
head, neck, or 
lung),weight loss 




 Children  4 
years of age, or 
infants, children 
and adolescents 
exposed to adults 
at high-risk 
†
 For persons who are otherwise at low risk for TB and who are 
tested at the start of employment, a reaction of 15 mm is 
considered positive. 
